RUNX3 and neoplasm: Although Runx3 restoration significantly extended the survival of KPRL/F mice (≈4.4 weeks), a comparison of the effect of Runx3 restoration with that on KRL/F mice (>18 weeks) (Figure 1D) indicates that the tumor-suppressive activity of Runx3 is largely dependent on p53.